Treatment success (all TB) | Default (all TB) | |||||
---|---|---|---|---|---|---|
Characteristic | Percent1 | Adjusted OR* (95% CI) | p-value | Percent1 | Adjusted OR* (95% CI) | p-value |
Sex | ||||||
Male | 45.5 | 1.00 | 37.5 | 1.00 | ||
Female | 49.4 | 1.15(1.08–1.23) | <0.001 | 34.0 | 0.88(0.82–0.94) | <0.001 |
Age group (years) | ||||||
0–14 | 42.6 | 0.83 (0.75–0.92) | <0.001 | 41.2 | 1.17 (1.06–1.30) | 0.002 |
15–24 (reference group) | 51.1 | 1.00 | 33.4 | 1.00 | ||
25–34 | 47.5 | 0.84(0.77–0.91) | <0.001 | 34.4 | 1.07 (0.98–1.17) | 0.14 |
35–44 | 45.7 | 0.76 (0.68–0.84) | <0.001 | 36.1 | 1.14 (1.03–1.28) | 0.02 |
45–54 | 44.9 | 0.69 (0.60–0.79) | <0.001 | 37.7 | 1.26 (1.09–1.46) | 0.002 |
55–64 | 51.4 | 1.04 (0.84–1.29) | 0.71 | 35.4 | 1.04 (0.81–1.27) | 0.90 |
≥ 65 | 37.4 | 0.67 (0.48–0.93) | 0.02 | 43.7 | 1.27 (0.92–1.726 | 0.15 |
Patient category | ||||||
New | 47.0 | 1.00 | 35.9 | 1.00 | ||
Transferred-in | 59.5 | 1.09 (0.89–1.36) | 0.40 | 35.7 | 1.19 (0.95–1.48) | 0.13 |
Return after default | 33.9 | 0.68 (0.51–0.92) | 0.01 | 52.9 | 1.57 (1.19–2.07) | 0.002 |
Treatment failure | 54.3 | 1.30 (0.91–1.86) | 0.15 | 23.6 | 0.72 (0.48–1.09) | 0.12 |
Relapse | 62.9 | 1.51(1.01–2.26) | 0.05 | 16.9 | 0.50 (0.30–0.82) | 0.006 |
TB type | ||||||
Pulmonary positive | 55.3 | 1.00 | 28.7 | 1.00 | ||
Pulmonary negative | 37.5 | 0.55 (0.50–0.60) | <0.001 | 43.7 | 2.06 (1.87–2.26) | <0.001 |
Extra-pulmonary | 42.4 | 0.51 (0.47–0.55) | <0.001 | 41.1 | 1.94 (1.78–2.11) | <0.001 |
Treatment regimen | ||||||
Short course chemotherapy | 55.5 | 1.00 | 27.7 | 1.00 | ||
Long course chemotherapy | 45.0 | 0.68 (0.62–0.75) | <0.001 | 40.9 | 1.46 (1.33–1.61) | <0.001 |
Treatment Centre** | ||||||
Hossana Hospital | 27.0 | 1.00 | 40.0 | 1.00 | ||
Lemmo district HF | 60.4 | 5.14 (4.62–5.72) | <0.001 | 20.6 | 0.28 (0.25–0.31) | <0.001 |
Shashogo district HF | 50.8 | 2.81 (2.41–3.28) | <0.001 | 44.1 | 1.18 (1.01–1.37) | 0.04 |
Misha district HF | 60.3 | 4.78 (4.23–5.39) | <0.001 | 33.0 | 0.58 (0.51–0.65) | <0.001 |
Gibe district HF | 60.7 | 4.78 (4.20–5.45) | <0.001 | 26.2 | 0.51 (0.45–0.59) | <0.001 |
Soro district HF | 50.5 | 2.70 (2.39–3.06) | <0.001 | 42.5 | 1.11 (0.98–1.26) | 0.09 |
Duna district HF | 30.2 | 0.77 (0.55–1.08) | 0.12 | 67.3 | 5.18 (3.71–7.24) | <0.001 |
Badewacho district HF | 41.1 | 1.64 (1.44–1.86) | <0.001 | 54.4 | 2.11 (1.86–2.40) | <0.001 |
Year of treatment | ||||||
1994 | 38.4 | 1.00 | 42.7 | 1.00 | ||
1995 | 40.6 | 1.18 (0.99–1.39) | 0.06 | 39.9 | 1.17 (1.00–1.37) | 0.05 |
1996 | 48.7 | 1.29 (1.10–1.51) | 0.002 | 33.3 | 0.83 (0.71–0.97) | 0.02 |
1997 | 38.9 | 0.72 (0.61–0.85) | <0.001 | 39.5 | 1.08 (0.93–1.27) | 0.32 |
1998 | 41.9 | 0.74 (0.63–0.87) | <0.001 | 43.8 | 1.20 (1.03–1.40) | 0.02 |
1999 | 56.7 | 1.37 (1.16–1.62) | <0.001 | 30.0 | 0.59 (0.5–0.70) | <0.001 |
2000 | 59.8 | 1.41 (1.18–1.69) | <0.001 | 25.8 | 0.54 (0.45–0.65) | <0.001 |